Global Dialysis Market

Dialysis Market Size, Share, Growth Analysis, By Type(Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD)), By Products and Services(Services, Equipment (Dialysis Machines, Water Treatment Systems, Others)), By End User(In-center Dialysis, Home Dialysis), By Region - Industry Forecast 2024-2031

Report ID: SQSG35A2061 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 87 | Figures: 76

Dialysis Market Competitive Landscape

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Top Players in Global Dialysis Market are

  • Asahi Kasei Corporation 
  • B. Braun Melsungen AG 
  • Baxter International Inc. 
  • Becton Dickinson and Company 
  • DaVita Inc. 
  • Fresenius Medical Care AG & Co. KGaA 
  • JMS Co. Ltd. 
  • Medtronic plc 
  • Nikkiso Co. Ltd. 
  • NIPRO Corporation 
  • Satellite Healthcare Inc. 
  • Toray Industries Inc. 
  • Diaverum Deutschland GmbH 
  • NxStage Medical, Inc. 
  • Rockwell Medical Technologies, Inc. 
  • AllMed Medical GmbH 
  • Fresenius Kabi AG 
  • Quanta Dialysis Technologies Ltd. 
  • Outset Medical, Inc. 
  • Medica S.p.A

Dialysis Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Asahi Kasei Corporation ', 'B. Braun Melsungen AG ', 'Baxter International Inc. ', 'Becton Dickinson and Company ', 'DaVita Inc. ', 'Fresenius Medical Care AG & Co. KGaA ', 'JMS Co. Ltd. ', 'Medtronic plc ', 'Nikkiso Co. Ltd. ', 'NIPRO Corporation ', 'Satellite Healthcare Inc. ', 'Toray Industries Inc. ', 'Diaverum Deutschland GmbH ', 'NxStage Medical, Inc. ', 'Rockwell Medical Technologies, Inc. ', 'AllMed Medical GmbH ', 'Fresenius Kabi AG ', 'Quanta Dialysis Technologies Ltd. ', 'Outset Medical, Inc. ', 'Medica S.p.A'

In terms of cost and healthcare services, the overall burden of end-stage renal disease (ESRD) and chronic kidney disease (CKD) is one of the highest. One of the primary drivers of market expansion is the increasing prevalence of chronic kidney disease and renal failure. ESRD occurs when one or both kidneys cease to function correctly and the patient requires long-term renal infusion therapy or a kidney transplant. Thus, the rising frequency of ESRD is increasing the global financial burden of kidney disorders and is one of the primary drivers driving the increased revenue generation from services. According to the CDC, around 15% of the US population and 14% of Hispanics have CKD.

Renal dialysis market trend has been identified as the shift of patients from clinics to homecare settings. Patients with end-stage renal disease (ESRD) must receive care at a renal facility or might choose to receive these treatments at home. One of the market's significant trends is the growing desire of patients for receiving care at home, particularly in developed economies. Furthermore, governments in countries such as the United States are working to establish new payment ways for treating renal illness, which may favor lower-cost care at home. This is expected to increase the number of patients seeking treatment in home care settings in the future years.

In 2021, North America is expected to have the biggest share of the market during the forecast period. The high prevalence of CKD and ESRD in the United States and Canada, together with greater treatment rates in these countries, are expected to drive market growth over the projected period. The increased incidence of coronavirus infections and resultant renal failures is also expected to increase demand for services and products in the United States.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Dialysis Equipment Market
Buy Now GET FREE SAMPLE
Home Dialysis Systems Market
Buy Now GET FREE SAMPLE
U.S. Dialysis Service Market
Buy Now GET FREE SAMPLE
Peritoneal Dialysis Market
Buy Now GET FREE SAMPLE
Urinalysis Market
Buy Now GET FREE SAMPLE
Cell Lysis Market
Buy Now GET FREE SAMPLE
Renal Biomakers Market
Buy Now GET FREE SAMPLE
Continuous Renal Replacement Therapy Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Dialysis Market

Report ID: SQSG35A2061

$5,300
BUY NOW GET FREE SAMPLE